UNIVO Directors

006

Nir Ben Zvi,CPA(MBA)

FOUNDER & BOARD MEMBER

Nir has more than 17 years of extensive international financial and operational experience. He is currently the CFO of Playbuzz Ltd, where he oversees all financial, legal, and operational aspects of the company. Prior to that, he was the CFO at Playscape, Team Leader at Ernst & Young and Budget and Control Manager at The Ministry of Defense. Nir holds a B.A. in Economics & Management with additional expansion in Accountancy, Tel Aviv University and an MBA in Financial Management from Tel Aviv University.

007

Eli Cohen

CHAIRMAN OF THE BOARD

Eli has 20 years’ experience in international business management. He held the position of director in several public companies (Hagag Yezom Nadlan and Hagag Europe investing LTD) and private companies like A. Ain Orim LTD and Neot Sigal LTD. Eli holds a B.A in Economics, and LLB and LLM degrees from Tel Aviv University School of Law and an Executive MBA degree from the Kellogg School of Management at Northwestern University, USA.

005

Meital Ran

BOARD MEMBER

Meital is the founder of Authorized Accountant Company Meital Ran. She has 20 years experience as an Internal Auditor at of the Israel Government. Meital is a CPA with degrees in LLB, and LLM. She is a Certified Internal Auditor from IIA, and an Information Systems Auditor from ISACA. She holds a Master of Laws (M.L.) from Bar Ilan University.

009

Dr. Shaul Mukhtar

CONSULTANT

Shaul has over 15 years’ experience in the pharmaceutical industry, notably with TEVA pharmaceuticals. He has vast experience in Research and Development (R&D), quality assurance, business and operational management. Shaul holds a PhD. in Pharmaceutical Sciences from the Hebrew University of Jerusalem, and Executive MBA degree from Kellogg- Recanati Business School.

010

Shmuel Rubinstein

BOARD MEMBER

Shmuel has served as CEO of Taro Pharmaceuticals Ltd. (a public company traded on NASDAQ) for over 21 years and helped growing the company from about a 10Milion USD to over 400Milion USD . At the pick of his time as CEO, the company was valued at 2 billion USD. The company was located in Israel ,USA ,Canada and with several offices in Europe. Under his leadership the company got all GMP approvals and many approvals of products in the USA and Europe. After retiring from Taro , Shmuel is serving as a director and consultant in several Pharma companies in Israel and USA.